MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image BIOGEN INC
BIOGEN INC

BIOGEN INC

HQ - Cambridge, MA

Summary

Biogen develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company products address diseases such as multiple sclerosis, non-hodgkin's lymphoma, rheumatoid arthritis, crohn's disease, and psoriasis.

Deals Overview

Total Deals9
Valued Deals9
Total Value£ 12.63 B
Avg. Deal Size£ 1.40 B

Market Context

Sort

04 Mar 2019|United Kingdom|Biotechnology
Nightstar Therapeutics
Biogen

Target: NIGHTSTAR THERAPEUTICS

Bidder: BIOGEN INC

8 Service Providers

5 Target | 3 Bidder

30 Dealmakers

27 Target | 4 Bidder

£ 663 M

Value

12 Mar 2019|Denmark|Pharmaceuticals
Biogen Denmark Manufacturing Aps
Fujifilm Holdings Corp

Target: BIOGEN DENMARK MANUFACTURING APS

Bidder: FUJIFILM HOLDINGS CORP

3 Service Providers

2 Bidder | 1 Vendor

7 Dealmakers

2 Bidder | 5 Vendor

£ 681 M

Value

27 Feb 2020|United States|Biotechnology
Sangamo Therapeutics
Biogen

Target: SANGAMO THERAPEUTICS INC

Bidder: BIOGEN INC

4 Service Providers

2 Target | 2 Bidder

8 Dealmakers

5 Target | 3 Bidder

£ 270 M

Value

27 Nov 2020|United States|Pharmaceuticals
Sage Therapeutics
Biogen

Target: SAGE THERAPEUTICS

Bidder: BIOGEN INC

5 Service Providers

2 Target | 3 Bidder

7 Dealmakers

3 Target | 4 Bidder

£ 1.13 B

Value

06 Aug 2020|United States|Biotechnology
Denali Therapeutics
Biogen

Target: DENALI THERAPEUTICS INC

Bidder: BIOGEN INC

5 Service Providers

2 Target | 3 Bidder

7 Dealmakers

2 Target | 5 Bidder

£ 780 M

Value

27 Jan 2022|South Korea|Biotechnology
Samsung Bioepis
Samsung Biologics

Target: SAMSUNG BIOEPIS

Bidder: SAMSUNG BIOLOGICS

8 Service Providers

1 Target | 3 Bidder | 4 Vendor

9 Dealmakers

5 Bidder | 4 Vendor

£ 1.71 B

Value

28 Jul 2023|United States|Pharmaceuticals
Reata Pharmaceuticals
Biogen

Target: REATA PHARMACEUTICALS INC

Bidder: BIOGEN INC

9 Service Providers

4 Target | 5 Bidder

60 Dealmakers

38 Target | 22 Bidder

£ 5.66 B

Value

22 May 2024|United States|Biotechnology
Human Immunology Biosciences
Biogen

Target: HUMAN IMMUNOLOGY BIOSCIENCES

Bidder: BIOGEN INC

7 Service Providers

5 Target | 2 Bidder

19 Dealmakers

4 Target | 15 Bidder

£ 1.42 B

Value

10 Jan 2025|United States|Pharmaceuticals
Sage Therapeutics
Biogen

Target: SAGE THERAPEUTICS

Bidder: BIOGEN INC

3 Service Providers

2 Target | 1 Bidder

6 Dealmakers

5 Target | 1 Bidder

£ 324 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite